In search of a selective antiviral chemotherapy

被引:221
作者
DeClercq, E
机构
关键词
D O I
10.1128/CMR.10.4.674
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
引用
收藏
页码:674 / +
页数:1
相关论文
共 198 条
[1]  
ADUMA P, 1995, MOL PHARMACOL, V47, P816
[2]   THE PETT SERIES, A NEW CLASS OF POTENT NONNUCLEOSIDE INHIBITORS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE [J].
AHGREN, C ;
BACKRO, K ;
BELL, FW ;
CANTRELL, AS ;
CLEMENS, M ;
COLACINO, JM ;
DEETER, JB ;
ENGELHARDT, JA ;
HOGBERG, M ;
JASKUNAS, SR ;
JOHANSSON, NG ;
JORDAN, CL ;
KASHER, JS ;
KINNICK, MD ;
LIND, P ;
LOPEZ, C ;
MORIN, JM ;
MUESING, MA ;
NOREEN, R ;
OBERG, B ;
PAGET, CJ ;
PALKOWITZ, JA ;
PARRISH, CA ;
PRANC, P ;
RIPPY, MK ;
RYDERGARD, C ;
SAHLBERG, C ;
SWANSON, S ;
TERNANSKY, RJ ;
UNGE, T ;
VASILEFF, RT ;
VRANG, L ;
WEST, SJ ;
ZHANG, H ;
XHOU, XX .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (06) :1329-1335
[3]   ON THE MECHANISM OF SELECTIVE-INHIBITION OF HERPESVIRUS REPLICATION BY (E)-5-(2-BROMOVINYL)-2'-DEOXYURIDINE [J].
ALLAUDEEN, HS ;
KOZARICH, JW ;
BERTINO, JR ;
DECLERCQ, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1981, 78 (05) :2698-2702
[4]   COMPARATIVE ACTIVITY OF SELECTED ANTIVIRAL COMPOUNDS AGAINST CLINICAL ISOLATES OF VARICELLA-ZOSTER VIRUS [J].
ANDREI, G ;
SNOECK, R ;
REYMEN, D ;
LIESNARD, C ;
GOUBAU, P ;
DESMYTER, J ;
DECLERCQ, E .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1995, 14 (04) :318-329
[5]   METABOLIC-FATE OF (E)-5-(2-BROMOVINYL)-2'-DEOXYURIDINE IN HERPES-SIMPLEX VIRUS-INFECTED AND MOCK-INFECTED CELLS [J].
AYISI, NK ;
DECLERCQ, E ;
WALL, RA ;
HUGHES, H ;
SACKS, SL .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 26 (05) :762-765
[6]  
BABA M, 1991, MOL PHARMACOL, V39, P805
[7]   PRECLINICAL EVALUATION OF MKC-442, A HIGHLY POTENT AND SPECIFIC INHIBITOR OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IN-VITRO [J].
BABA, M ;
SHIGETA, S ;
YUASA, S ;
TAKASHIMA, H ;
SEKIYA, K ;
UBASAWA, M ;
TANAKA, H ;
MIYASAKA, T ;
WALKER, RT ;
DECLERCQ, E .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (04) :688-692
[8]   POTENT AND SELECTIVE-INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) BY 5-ETHYL-6-PHENYLTHIOURACIL DERIVATIVES THROUGH THEIR INTERACTION WITH THE HIV-1 REVERSE-TRANSCRIPTASE [J].
BABA, M ;
DECLERCQ, E ;
TANAKA, H ;
UBASAWA, M ;
TAKASHIMA, H ;
SEKIYA, K ;
NITTA, I ;
UMEZU, K ;
NAKASHIMA, H ;
MORI, S ;
SHIGETA, S ;
WALKER, RT ;
MIYASAKA, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (06) :2356-2360
[9]   HIGHLY SPECIFIC-INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 BY A NOVEL 6-SUBSTITUTED ACYCLOURIDINE DERIVATIVE [J].
BABA, M ;
TANAKA, H ;
DECLERCQ, E ;
PAUWELS, R ;
BALZARINI, J ;
SCHOLS, D ;
NAKASHIMA, H ;
PERNO, CF ;
WALKER, RT ;
MIYASAKA, T .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 165 (03) :1375-1381
[10]   OXATHIIN CARBOXANILIDE, A POTENT INHIBITOR OF HUMAN-IMMUNODEFICIENCY-VIRUS REPRODUCTION [J].
BADER, JP ;
MCMAHON, JB ;
SCHULTZ, RJ ;
NARAYANAN, VL ;
PIERCE, JB ;
HARRISON, WA ;
WEISLOW, OS ;
MIDELFORT, CF ;
STINSON, SF ;
BOYD, MR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (15) :6740-6744